Manipulation of host diet to reduce gastrointestinal colonization by the opportunistic pathogen Candida albicans

mSphere

Volumn 1, Issue 1, 2016, Pages

  Gunsalus, Kearney T W ^a,b   Tornberg Belanger, Stephanie N ^b,d   Matthan, Nirupa R ^c   Lichtenstein, Alice H ^c   Kumamoto, Carol A ^b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY   (United States)

^d UNIVERSITY OF NEW HAMPSHIRE   (United States)

Author keywords

Candida; Candida albicans; Carbon metabolism; Commensal; Fatty acids; Host pathogen interactions; Medium chain fatty acids; Microbiome; Pathogenesis

Indexed keywords

EID: 84962107161     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00020-15     Document Type: Article

References (65)

1. Gudlaugsson O, Gillespie S, Lee K, Vande Berg JV, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D. 2003. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37:1172-1177. http:// dx.doi.org/10.1086/378745
2. Diekema DJ, Pfaller MA. 2004. Nosocomial candidemia: an ounce of prevention is better than a pound of cure. Infect Control Hosp Epidemiol 25:624-626. http://dx.doi.org/10.1086/502451
3. Nucci M, Anaissie E. 2001. Revisiting the source of candidemia: skin or gut? Clin Infect Dis 33:1959-1967. http://dx.doi.org/10.1086/323759
4. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. 1997. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24:1122-1128. http://dx.doi.org/ 10.1086/513663
5. Aydemir C, Oguz SS, Dizdar EA, Akar M, Sarikabadayi YU, Saygan S, Erdeve O, Dilmen U. 2011. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 96:F164-F168. http://dx.doi.org/10.1136/ adc.2009.178996
6. Bertini G, Perugi S, Dani C, Filippi L, Pratesi S, Rubaltelli FF. 2005. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr 147:162-165. http://dx.doi.org/ 10.1016/j.jpeds.2005.02.020
7. Clerihew L, Austin N, McGuire W. 2007. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev 4:CD003850. http://dx.doi.org/ 10.1002/14651858.CD003850.pub3:CD003850
8. Faiz S, Neale B, Rios E, Campos T, Parsley E, Patel B, Ostrosky-Zeichner L. 2009. Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit. Eur J Clin Microbiol Infect Dis 28:689-692. http://dx.doi.org/10.1007/s10096-008-0666-4
9. Manzoni P, Arisio R, Mostert M, Leonessa M, Farina D, Latino MA, Gomirato G. 2006. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics 117: e22-e32. http://dx.doi.org/10.1542/peds.2004-2227
10. Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G, Tridapalli E, Corona G, Giovannozzi C, Farina D, Arisio R, Merletti F, Maule M, Mosca F, Pedicino R, Stronati M, Mostert M, Gomirato G, Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology 2007. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 356:2483-2495. http://dx.doi.org/10.1056/NEJMoa065733
11. McCrossan BA, McHenry E, O'Neill F, Ong G, Sweet DG. 2007. Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection. Arch Dis Child Fetal Neonatal Ed 92:F454-F458. http:// dx.doi.org/10.1136/adc.2006.094359
12. Rolnitsky A, Levy I, Sirota L, Shalit I, Klinger G. 2012. Targeted fluconazole prophylaxis for high-risk very low birth weight infants. Eur J Pediatr 171:1481-1487. http://dx.doi.org/10.1007/s00431-012-1760-2
13. Uko S, Soghier LM, Vega M, Marsh J, Reinersman GT, Herring L, Dave VA, Nafday S, Brion LP. 2006. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics 117:1243-1252. http://dx.doi.org/10.1542/ peds.2005-1969
14. Weitkamp J, Ozdas A, LaFleur B, Potts AL. 2008. Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure. J Perinatol 28:405-411. http:// dx.doi.org/10.1038/sj.jp.7211914
15. Healy CM, Campbell JR, Zaccaria E, Baker CJ. 2008. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics 121:703-710. http://dx.doi.org/10.1542/ peds.2007-1130
16. Kaufman D. 2008. Fluconazole prophylaxis decreases the combined outcome of invasive Candida infections or mortality in preterm infants. Pediatrics 122:1158-1159. http://dx.doi.org/10.1542/peds.2008-1837
17. Playford EG, Webster AC, Sorrell TC, Craig JC. 2006. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 57:628-638. http://dx.doi.org/ 10.1093/jac/dki491
18. Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME. 2006. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebocontrolled trials. Crit Care Med 34:1216-1224. http://dx.doi.org/10.1097/ 01.CCM.0000208357.05675.C3
19. Anderson JB. 2005. Evolution of antifungal-drug resistance: mechanisms and pathogen fitness. Nat Rev Microbiol 3:547-556. http:// dx.doi.org/10.1038/nrmicro1179
20. Cowen LE, Anderson JB, Kohn LM. 2002. Evolution of drug resistance in Candida albicans. Annu Rev Microbiol 56:139-165. http://dx.doi.org/ 10.1146/annurev.micro.56.012302.160907
21. Rex JH. 2006. Antifungal prophylaxis in the intensive care unit: who should get it? Crit Care Med 34:1286-1287. http://dx.doi.org/10.1097/ 01.CCM.0000208110.36504.19
22. Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. 2013. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 62:10-24. http://dx.doi.org/10.1099/ jmm.0.045054-0
23. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/drugresistance/threatreport-2013/
24. De Wit N, Derrien M, Bosch-Vermeulen H, Oosterink E, Keshtkar S, Duval C, de Vogel-van den Bosch J, Kleerebezem M, Muller M, van der Meer R. 2012. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol Gastrointest Liver Physiol 303:G589-G599. http://dx.doi.org/10.1152/ajpgi.00488.2011
25. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen Y, Knight R, Ahima RS, Bushman F, Wu GD. 2009. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137:1716-1724. http:// dx.doi.org/10.1053/j.gastro.2009.08.042
26. Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O, Fouhy F, Clarke SF, O'Toole PW, Quigley EM, Stanton C, Ross PR, O'Doherty RM, Shanahan F. 2010. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59:1635-1642. http://dx.doi.org/10.1136/gut.2010.215665
27. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3:213-223. http://dx.doi.org/ 10.1016/j.chom.2008.02.015
28. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. 2009. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1:6ra14. http:// dx.doi.org/10.1126/scitranslmed.3000322
29. Maukonen J, Saarela M. 2015. Human gut microbiota: does diet matter? Proc Nutr Soc 74:23-36. http://dx.doi.org/10.1017/ S0029665114000688
30. Shen W, Gaskins HR, McIntosh MK. 2014. Influence of dietary fat on intestinal microbes, inflammation, barrier function and metabolic outcomes. J Nutr Biochem 25:270-280. http://dx.doi.org/10.1016/ j.jnutbio.2013.09.009
31. Ogbolu DO, Oni AA, Daini OA, Oloko AP. 2007. In vitro antimicrobial properties of coconut oil on Candida species in Ibadan, Nigeria. J Med Food 10:384-387. http://dx.doi.org/10.1089/jmf.2006.1209
32. Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. 1972. Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother 2:23-28. http://dx.doi.org/10.1128/AAC.2.1.23
33. Bergsson G, Arnfinnsson J, Steingrimsson O, Thormar H. 2001. In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob Agents Chemother 45:3209-3212. http://dx.doi.org/ 10.1128/AAC.45.11.3209-3212.2001
34. Strijbis K, van Roermund CWT, Visser WF, Mol EC, van den Burg J, MacCallum DM, Odds FC, Paramonova E, Krom BP, Distel B. 2008. Carnitine-dependent transport of acetyl coenzyme A in Candida albicans is essential for growth on nonfermentable carbon sources and contributes to biofilm formation. Eukaryot Cell 7:610-618. http://dx.doi.org/ 10.1128/EC.00017-08
35. Zhou H, Lorenz MC. 2008. Carnitine acetyltransferases are required for growth on non-fermentable carbon sources but not for pathogenesis in Candida albicans. Microbiology 154:500-509. http://dx.doi.org/10.1099/ mic.0.2007/014555-0
36. Carman AJ, Vylkova S, Lorenz MC. 2008. Role of acetyl coenzyme A synthesis and breakdown in alternative carbon source utilization in Candida albicans. Eukaryot Cell 7:1733-1741. http://dx.doi.org/10.1128/ EC.00253-08
37. Prigneau O, Porta A, Maresca B. 2004. Candida albicans CTN gene family is induced during macrophage infection: homology, disruption and phenotypic analysis of CTN3 gene. Fungal Genet Biol 41:783-793. http://dx.doi.org/10.1016/j.fgb.2004.04.001
38. Ramirez MA, Lorenz MC. 2009. The transcription factor homolog CTF1 regulates β-oxidation in Candida albicans. Eukaryot Cell 8:1604-1614. http://dx.doi.org/10.1128/EC.00206-09
39. Strijbis K, Distel B. 2010. Intracellular acetyl unit transport in fungal carbon metabolism. Eukaryot Cell 9:1809-1815. http://dx.doi.org/ 10.1128/EC.00172-10
40. Kunau W, Dommes V, Schulz H. 1995. Beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress. Prog Lipid Res 34:267-342. http://dx.doi.org/10.1016/0163-7827(95)00011-9
41. Agricultural Research Service. 2015. Full report (all nutrients) 04047, oil, coconut. Agricultural Research Service, US Department of Agriculture, Washington, DC
42. Barelle CJ, Priest CL, Maccallum DM, Gow NAR, Odds FC, Brown AJP. 2006. Niche-specific regulation of central metabolic pathways in a fungal pathogen. Cell Microbiol 8:961-971. http://dx.doi.org/10.1111/j.1462-5822.2005.00676.x
43. Piekarska K, Mol E, van den Berg M, Hardy G, van den Burg J, van Roermund C, MacCallum D, Odds F, Distel B. 2006. Peroxisomal fatty acid beta-oxidation is not essential for virulence of Candida albicans. Eukaryot Cell 5:1847-1856. http://dx.doi.org/10.1128/EC.00093-06
44. Prigneau O, Porta A, Poudrier JA, Colonna-Romano S, Noël T, Maresca B. 2003. Genes involved in beta-oxidation, energy metabolism and glyoxylate cycle are induced by Candida albicans during macrophage infection. Yeast 20:723-730. http://dx.doi.org/10.1002/yea.998
45. Ramirez MA, Lorenz MC. 2007. Mutations in alternative carbon utilization pathways in Candida albicans attenuate virulence and confer pleiotropic phenotypes. Eukaryot Cell 6:280-290. http://dx.doi.org/10.1128/ EC.00372-06
46. Lorenz MC, Fink GR. 2001. The glyoxylate cycle is required for fungal virulence. Nature 412:83-86. http://dx.doi.org/10.1038/35083594
47. Brown AJP, Brown GD, Netea MG, Gow NAR. 2014. Metabolism im-pacts upon Candida immunogenicity and pathogenicity at multiple levels. Trends Microbiol 22:614-622. http://dx.doi.org/10.1016/ j.tim.2014.07.001
48. Fradin C, De Groot P, MacCallum D, Schaller M, Klis F, Odds FC, Hube B. 2005. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol 56:397-415. http://dx.doi.org/10.1111/j.1365-2958.2005.04557.x
49. Lorenz MC, Bender JA, Fink GR. 2004. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell 3:1076-1087. http://dx.doi.org/10.1128/EC.3.5.1076-1087.2004
50. Marten B, Pfeuffer M, Schrezenmeir J. 2006. Medium-chain triglycerides. Int Dairy J 16:1374-1382. http://dx.doi.org/10.1016/ j.idairyj.2006.06.015
51. Agricultural Research Service. 2012. Nutrient intakes from food: mean amounts consumed per individual, by gender and age; what we eat in America, NHANES 2009-2010. Agricultural Research Service, US Department of Agriculture, Washington, DC. http://www.ars.usda.gov/ba/ bhnrc/fsrg
52. Vargas SL, Patrick CC, Ayers GD, Hughes WT. 1993. Modulating effect of dietary carbohydrate supplementation on Candida albicans colonization and invasion in a neutropenic mouse model. Infect Immun 61: 619-626
53. Weig M, Werner E, Frosch M, Kasper H. 1999. Limited effect of refined carbohydrate dietary supplementation on colonization of the gastrointestinal tract of healthy subjects by Candida albicans. Am J Clin Nutr 69:1170-1173
54. Reeves PG, Nielsen FH, Fahey GC, Jr. 1993. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951
55. White SJ, Rosenbach A, Lephart P, Nguyen D, Benjamin A, Tzipori S, Whiteway M, Mecsas J, Kumamoto CA. 2007. Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog 3:e184. http://dx.doi.org/10.1371/journal.ppat.0030184
56. R Core Team. 2012. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
57. Pinheiro J, Bates D, DebRoy S, Sarkar D, R Core Team. 2015. nlme: linear and nonlinear mixed effects models. R package version 3.1-122. R Foundation for Statistical Computing, Vienna, Austria
58. Hothorn T, Bretz F, Westfall P. 2008. Simultaneous inference in general parametric models. Biom J 50:346-363. http://dx.doi.org/10.1002/ bimj.200810425
59. Nailis H, Coenye T, Van Nieuwerburgh F, Deforce D, Nelis HJ. 2006. Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR. BMC Mol Biol 7:25. http://dx.doi.org/10.1186/1471-2199-7-25
60. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034. http://dx.doi.org/10.1186/gb-2002-3-7-research0034
61. Kohl M. 2007. SLqPCR: functions for analysis of real-time quantitative PCR data at SIRS-Lab GmbH. SIRS-Lab GmbH, Jena, Germany
62. Willems E, Leyns L, Vandesompele J. 2008. Standardization of realtime PCR gene expression data from independent biological replicates. Anal Biochem 379:127-129. http://dx.doi.org/10.1016/j.ab.2008.04.036
63. Folch J, Lees M, Sloane SGH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509
64. Morrison WR, Smith LM. 1964. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron-fluoride-methanol. J Lipid Res 5:600-608
65. Matthan NR, Ip B, Resteghini N, Ausman LM, Lichtenstein AH. 2010. Long-term fatty acid stability in human serum cholesteryl ester, triglyceride, and phospholipid fractions. J Lipid Res 51:2826-2832. http:// dx.doi.org/10.1194/jlr.D007534